ストックスクリーナーアプリを入手
1.32
1.91%
0.01
アフターアワーズ：
1.32
前日終値:
$1.31
開ける：
$1.32
24時間の取引高:
67,356
Relative Volume:
1.52
時価総額：
$64.97M
収益：
$596.60K
当期純損益:
$-11.72M
株価収益率:
-5.5323
EPS:
-0.2386
ネットキャッシュフロー:
$-9.51M
1週間 パフォーマンス:
+1.14%
1か月 パフォーマンス:
-1.11%
6か月 パフォーマンス:
-16.56%
1年 パフォーマンス:
+1.91%
1日の値動き範囲:
$1.3011
$1.34
1週間の範囲:
$1.3001
$1.4386
52週間の値動き範囲:
$1.168
$1.96
Medicinova Inc Stock (MNOV) Company Profile
Compare MNOV vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.32 | 64.48M | 596.60K | -11.72M | -9.51M | -0.2386 |
VRTX
Vertex Pharmaceuticals Inc
|
515.57 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.86 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
986.80 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
211.94 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.66 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-16 | 開始されました | H.C. Wainwright | Buy |
| 2021-03-10 | 開始されました | Maxim Group | Buy |
| 2019-03-25 | 再開されました | B. Riley FBR | Buy |
| 2018-03-28 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | 開始されました | Credit Suisse | Outperform |
| 2013-01-04 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2012-05-24 | ダウングレード | MLV & Co | Buy → Hold |
| 2011-10-18 | 繰り返されました | MLV Capital | Buy |
| 2011-06-22 | 開始されました | Global Hunter Securities | Buy |
| 2010-05-12 | 開始されました | Wedbush | Outperform |
| 2008-11-12 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2008-05-15 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | 開始されました | Punk, Ziegel & Co | Buy |
すべてを表示
Medicinova Inc (MNOV) 最新ニュース
FY2028 EPS Estimates for MediciNova Lowered by HC Wainwright - MarketBeat
MediciNova Inc (NASDAQ: MNOV) Share Price, MNOV Stock News, MNOV Share Price & Updates - Kalkine
MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
MediciNova (NASDAQ:MNOV) Announces Quarterly Earnings Results - MarketBeat
MediciNova Inc reports results for the quarter ended June 30Earnings Summary - TradingView
MediciNova: Q2 Earnings Snapshot - AOL.com
MNOV: Q2 2026 revenue grew and net loss narrowed, with cash reserves supporting operations into 2027 - TradingView
MNOV Q2'26 Earnings: EPS estimate is (0.06) USD - TradingView
MediciNova Inc (MNOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MediciNova Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
MNOV Q2'26 Earnings: revenue estimate is 75.00K USD - TradingView
MediciNova (MNOV) Projected to Release Earnings on Thursday - MarketBeat
Price to book forward of MediciNova, Inc. – NASDAQ:MNOV - tradingview.com
MediciNova, Inc. Revenue Breakdown – NASDAQ:MNOV - TradingView
MediciNova Inc (MNOV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MediciNova Inc (MNOV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MediciNova Inc (MNOV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
MediciNova Inc (MNOV) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
MediciNova Inc (MNOV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to EBIT forward of MediciNova, Inc. – NASDAQ:MNOV - TradingView
Price to sales forward of MediciNova, Inc. – NASDAQ:MNOV - TradingView
Enterprise value to EBIT forward of MediciNova, Inc. – TSE:4875 - TradingView
MediciNova stock trades steady as investors weigh recent losses and pipeline progress - Ad-hoc-news.de
Price to sales forward of MediciNova, Inc. – TSE:4875 - TradingView
MediciNova stock trades steady as pipeline progress contrasts with lower recent revenues - Ad-hoc-news.de
Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Legend Biotech (LEGN) and AngioDynamics (ANGO) - The Globe and Mail
MediciNova, Inc. (NASDAQ:MNOV) Sees Significant Increase in Short Interest - MarketBeat
H.C. Wainwright Maintains MediciNova(MNOV.US) With Buy Rating, Maintains Target Price $10 - Moomoo
MediciNova reaches 200-patient enrollment in ALS study - Investing.com
MediciNova reaches 200-patient enrollment in ALS study By Investing.com - Investing.com Nigeria
ALS patients ineligible for trials join MediciNova's 200-person study - Stock Titan
MNOV Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Progress ContinuesOperating Income Trends - DonanımHaber
D Boral Capital maintains MediciNova (MNOV) buy recommendation - MSN
MediciNova Inc outlines its biotech pipeline as investors watch MN-166 progress - Ad-hoc-news.de
Medicinova Inc (MNOV) Holds Steady Near Support After Modest AdvanceFactor Crowding - dars.gov.et
Medicinova Inc (MNOV) Surges 7.6% as Biotech Stock Tests Resistance at $1.49Opening Range Breakout - dars.gov.et
Enterprise value to revenue forward of MediciNova, Inc. – TSE:4875 - TradingView
Price to earnings forward of MediciNova, Inc. – TSE:4875 - TradingView
Enterprise value to EBITDA forward of MediciNova, Inc. – NASDAQ:MNOV - TradingView
MediciNova completes patient visits in phase 2 NAFLD trial - Investing.com
MediciNova CEO Provides Shareholder Update - GlobeNewswire
Medicinova Inc (MNOV) Edges Higher: Biotech Stock Tests Resistance After Modest GainPrice Target - dars.gov.et
Medicinova Inc (MNOV) Edges Higher as Stock Holds Above Key SupportIV Spike - dars.gov.et
Medicinova Inc (MNOV) Edges Higher, Holds Above Key Support Amid Low-Volume TradeBPI Reversal - dars.gov.et
MNOV Q1 2026 Earnings: EPS Beat Drives Positive Stock Reaction Despite No RevenueQuarterly Profit Report - dars.gov.et
MediciNova, Inc. Actuals & Estimates (NASDAQ:MNOV) - TradingView
Form 4 MediciNova Inc For: 25 June By Investing.com - Investing.com Nigeria
MediciNova (MNOV) director awarded 44,500 stock options - Stock Titan
MediciNova (MNOV) director Nicole Lemerond receives 44,500 stock options grant - Stock Titan
Medicinova Inc (MNOV) 財務データ
収益
当期純利益
現金流量
EPS
2.67%
0.04%
大文字化:
|
ボリューム (24 時間):